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Abstract
Machine learning methods have been increasingly used to predict the conversion of mild cognitive 
impairment (MCI) to Alzheimer's disease (AD), by classifying MCI converters (MCI-C) from 
MCI non-converters (MCI-NC). However, most of existing methods construct classifiers using 
only data from one particular target domain (e.g., MCI), and ignore data in the other related 
domains (e.g., AD and normal control (NC)) that could provide valuable information to promote 
the performance of MCI conversion prediction. To this end, we develop a novel domain transfer 
learning method for MCI conversion prediction, which can use data from both the target domain 
(i.e., MCI) and the auxiliary domains (i.e., AD and NC). Specifically, the proposed method 
consists of three key components: 1) a domain transfer feature selection (DTFS) component that 
selects the most informative feature-subset from both target domain and auxiliary domains with 
different imaging modalities, 2) a domain transfer sample selection (DTSS) component that selects 
the most informative sample-subset from the same target and auxiliary domains with different data 
1Data used in this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative database (http://adni.loni.usc.edu/).
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modalities, and 3) a domain transfer support vector machine (DTSVM) classification component 
that fuses the selected features and samples to separate MCI-C and MCI-NC patients. We evaluate 
our method on 202 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) with 
MRI, FDG-PET and CSF data. The experimental results show that the proposed method can 
classify MCI-C patients from MCI-NC patients with an accuracy of 79.4%, with the aid of 
additional domain knowledge learned from AD and NC.
Index Terms
Domain Transfer Learning; Feature Selection; Sample Selection; Mild Cognitive Impairment 
Converters; Alzheimer's Disease
I. Introduction1
Alzheimer's disease (AD) is characterized by the progressive impairment of neurons and 
their connections, which result in loss of cognitive functions. In 2007, a report published by 
Ron et al. indicated that there were 26.6 million AD sufferers worldwide, and forecasted that 
1 in 85 people will be affected by 2050 [1]. As the prodromal stage of AD, mild cognitive 
impairment (MCI) can be further categorized into MCI converters (MCI-C) and MCI non-
converters (MCI-NC). Specifically, MCI-C patients will likely progress to AD, while MCI-
NC patients will not convert to AD. Existing research has suggested that the individuals with 
amnestic MCI tend to progress to the probable AD at a rate of approximately 10% to 15% 
per year [1]. Thus, the accurate diagnosis of AD, especially in the early stage (i.e., MCI), is 
very important for timely therapy, disease modifying drug development, and possible delay 
of the disease. Nowadays, many machine learning methods have been proposed to recognize 
AD patients [2–10]. Recently, an increasing number of studies on AD research begin to 
address classification of MCI conversion (MCI-C) and MCI non-conversion (MCI-NC) 
patients based on the high-resolution brain imaging data [4, 7, 11–24].
One challenge for MCI-C prediction is that the number of MCI-C and MCI-NC subjects 
available for training is generally very small, while the dimensionality of data is often very 
high, which makes it very challenging to train an accurate classifier. Thus, many advanced 
machine learning methods have been proposed to address this issue [2,3,7,11, 22,23,49–
51,57]. For instance, in [3], a multi-task learning method achieved an accuracy of 73.9% on 
43 MCI-C and 48 MCI-NC patients using multi-modality data such as MRI, 
fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid 
(CSF). In [7], a manifold harmonic transform method using cortical thickness data achieved 
a sensitivity of 63% and specificity of 76% on 72 MCI-C and 131 MCI-NC patients, and in 
[11] a morphological factor method using MRI data achieved an accuracy of 72.3% on 20 
MCI-C and 29 MCI-NC patients. In [22], an orthogonal partial least square to latent 
structures was used to diagnosis of MCI-C and achieved prediction accuracy of 75.4% and 
68% for those MCI subjects converting to AD by 24 and 36 months, respectively. This 
performance was reported on 162 MCI ADNI patients. In [23], a Gaussian process approach 
1Data used in this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative database (http://adni.loni.usc.edu/).
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that combined several multi-modality data sources (i.e., MRI, PET, CSF and APOE 
genotype) was used for classification and achieved an accuracy of 74.1% on classification 
between 47 MCI-C and 96 MCI-NC patients. In all these referenced studies, the size of 
dataset is small and also only one domain (i.e., MCI-C and MCI-NC) of subjects is used for 
training the classification models.
It is worth noting that MCI cohorts are heterogeneous, consisting of MCI-C (that will 
convert to AD) and MCI-NC (that will remain stable). Because of the characteristic of MCI 
cohorts, several studies proposed a hypothesis that the MCI-NC subjects are more healthy-
like, while the MCI-C subjects are more AD-like, which is consistent with the contention 
that discrete disease states are an approximation to a continuous disease spectrum [23, 40, 
56]. In the literature, several studies have treated AD as MCI-C, and NC as MCI-NC, and 
then used AD and NC subjects to train a support vector machine (SVM) for MCI-C 
prediction [23–25]. It demonstrates that the task of classifying MCI-C and MCI-NC subjects 
is related to the task of classifying AD and NC subjects. On the other hand, in machine 
learning community, transfer learning has been developed to better deal with the problem 
involving multiple domains (including target domain and auxiliary domain) of data [26–28], 
where it does not assume that the auxiliary data have exactly the same distribution as the 
target data. Recently, in our preliminary work [29], transfer learning has been introduced 
into medical imaging analysis. Specifically, in [29] a domain transfer support vector 
machine (DTSVM) was used to classify MCI-C and MCI-NC patients (i.e., target data) with 
the help of AD and NC patients as the auxiliary data, showing a great performance 
improvement. However, in [29], it did not use a feature selection step to identify the most 
discriminative features from imaging data. Also, in [29] all the patients in the auxiliary 
domain were used for training, without a step to select the most informative samples in the 
auxiliary domain (i.e., AD/NC subjects) for further improving the classification performance 
between MCI-C and MCI-NC patients.
To address the above-mentioned limitations, we propose a novel domain transfer learning 
framework for MCI-C prediction. Specifically, we first develop a domain transfer feature 
selection (DTFS) method by using both the auxiliary (AD/NC) and target (MCI-C/MCI-NC) 
domains to select a subset of discriminative features, common to both domains. Then, using 
the instance-transfer approach, a cross-domain kernel is constructed for transferring the 
auxiliary domain knowledge. To improve the quality of the source data in the cross-domain 
kernels, a domain transfer sample selection (DTSS) method is further developed using the 
multi-task least absolute shrinkage selection operator (Lasso) kernel-based method to select 
the most informative sample subset. Finally, all selected samples are classified by a domain 
transfer support vector machine (DTSVM) using adaptive SVMs and multi-kernel learning. 
The proposed method is evaluated using MRI, FDG-PET and CSF data of 202 subjects from 
the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and experimental results show 
that the proposed method can recognize MCI-C patients from MCI-NC ones with 79.4% 
accuracy by using the aid of additional domain knowledge learned from AD and NC.
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II. MATERIALS AND METHODS
The data used in our experiments came from the Alzheimer’s Disease Neuroimaging 
Initiative (ADNI) database. The ADNI was launched in 2003 by the National Institute on 
Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the 
Food and Drug Administration (FDA), private pharmaceutical companies, and non-profit 
organizations, as a $60 million, 5-year public-private partnership. The primary goal of 
ADNI has been to test whether the serial MRI, PET, other biological markers, and clinical 
and neuropsychological assessments can be combined to measure the progression of MCI 
and early AD. Determination of sensitive and specific markers of very early AD progression 
is intended to aid researchers and clinicians to develop new treatments and monitor their 
effectiveness, as well as lessen the time and cost of clinical trials.
ADNI is the result of efforts of many co-investigators from a broad range of academic 
institutions and private corporations, and subjects have been recruited from over 50 sites 
across the U.S. and Canada. The initial goal of ADNI was to recruit 800 adults, aged 55 to 
90, to participate in the research (approximately 200 cognitively normal older individuals to 
be followed for 3 years, 400 people with MCI to be followed for 3 years, and 200 people 
with early AD to be followed for 2 years). The research protocol was approved by each local 
institutional review board and the written informed consent is obtained from each 
participant.
A. Subjects
In the ADNI database, there are totally 202 subjects with three modality data (i.e., MRI, 
PET, and CSF), including 51 AD patients, 99 MCI patients (including 43 MCI converters 
(MCI-C) and 56 MCI non-converters (MCI-NC)), and 52 normal controls. During the 24-
month follow-up period, 43 MCI subjects converted to AD and 56 remained stable. It is 
worth noting the subject size used in our experiments is very similar to that used in many 
previous studies [2, 3, 29], and thus is sufficient to compare our proposed method with other 
methods. In general, the inclusion/exclusion criteria are listed below, and Table 1 provides a 
summary.
• MCI subjects: MMSE scores between 24–30, a memory complaint, having 
objective memory loss measured by education adjusted scores on Wechsler 
Memory Scale Logical Memory II, a CDR of 0.5, and absence of significant levels 
of impairment in other cognitive domains, essentially preserved activities of daily 
living, and an absence of dementia.
• Mild AD: MMSE scores between 20–26, CDR of 0.5 or 1.0, and meeting the 
National Institute of Neurological and Communicative Disorders and Stroke and 
the Alzheimer ’s disease and Related Disorders Association (NINCDS/ADRDA) 
criteria for probable AD.
• Healthy subjects: MMSE scores between 24–30, a Clinical Dementia Rating (CDR) 
of 0, non-depressed, non MCI, and non-demented.
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B. MRI, CSF, and PET biomarkers
A detailed description on how the MRI, CSF and PET datasets were acquired can be found 
in the public ADNI website. In general, structural MR scans were acquired from 1.5T or 
3.0T scanners. Raw DICOM MRI scans were downloaded from the public ADNI website 
(http://adni.loni.usc.edu/) reviewed for quality, and automatically corrected for spatial 
distortion caused by gradient nonlinearity and B1 field inhomogeneity. PET images were 
acquired 30–60 minutes post-injection, averaged, spatially aligned, interpolated to a standard 
voxel size, intensity normalized, and smoothed to a common resolution of 8mm full width at 
half maximum. CSF data were collected in the morning after an overnight fast using a 20- or 
24-gauge spinal needle, frozen within 1 hour of collection, and transported on dry ice to the 
ADNI Biomarker Core laboratory at the University of Pennsylvania Medical Center. In this 
study, amyloid β (Aβ42), CSF total tau (t-tau) and tau hyperphosphorylated at threonine 181 
(p-tau) are used as features.
C. Image analysis
The MRI and PET images are pre-processed to extract ROI-based features, by following the 
pipeline in [2]. Specifically, we first perform an anterior commissure (AC)-posterior 
commissure (PC) correction on all MRI and PET images using MIPAV software [30]. The 
AC-PC corrected images are resampled to 256×256×256, and the N3 algorithm [31] is then 
used to correct the intensity inhomogeneity. For the MR images, the skull is stripped using 
the method described in [32], followed by manual editing and cerebellum removal. Next, we 
use FAST in the FSL package [33] to segment the human brain into three different types of 
tissues: gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF). For a given 
brain image with three segmented tissues (i.e., GM, WM and CSF), we then non-linearly 
register it to a template with 93 manually labeled regions-of-interests (ROIs) [35], by using a 
widely-used high-dimensional elastic warping tool (i.e., HAMMER [34]). Finally, we use 
the volumes of GM tissue of the 93 ROIs, which were normalized by the total intracranial 
volume (which is estimated by the summation of GM, WM and CSF volumes from all 
ROIs), as features for a given subject. For PET image, we first align it to its corresponding 
MRI image of the same subject through affine transformation, and then compute the average 
intensity of each ROI in the PET image as features. In addition, three CSF biomarkers are 
also used in this study, namely CSF Aβ42, CSF t-tau and CSF p-tau. As a result, for each 
subject, we have 93 features derived from the MRI image, 93 features generated from the 
PET image, and 3 features obtained from the CSF biomarkers.
D. Domain transfer learning for MCI-C prediction
The system diagram illustrated in Fig. 1 outlines the steps and components used in our 
proposed classification framework. In general, it contains four components, i.e., image pre-
processing, domain transfer feature selection (DTFS), domain transfer sample selection 
(DTSS), and domain transfer support vector machine (DTSVM). At first, all MRI and PET 
images are pre-processed to get the extracted features as described in Section II.C. Then, for 
both MRI and PET features, the DTFS component identifies a subset of features 
(corresponding to brain regions) that are relevant to the disease under study. Next, the DTSS 
component uses the multi-modality features found by the DTFS component, as well as the 
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CSF features, to compute cross-domain kernels that simultaneously select the most 
informative cross-domain sample subset. Finally, in the DTSVM component, the auxiliary 
domain and cross-domain kernels are combined to train the ultimate classifier for classifying 
MCI-C and MCI-NC patients. In what follows, we will provide the technical details of these 
three components (i.e., DTFS, DTSS and DTSVM).
1) Domain transfer feature selection (DTFS)—In traditional single-domain learning, 
we can employ sparse logistic regression [43] for learning weight vectors wA and wT from 
the auxiliary and target domains, respectively. Then, we can use weight vectors wA and wT 
for feature selection. Although using single-domain sparse learning can achieve better 
performance for MCI-C prediction [44], it cannot acquire knowledge from cross-domain. 
Since the task of classifying MCI-C and MCI-NC patients is related to the task of classifying 
NC and AD patients, we combine these two learning domains for learning a common weight 
matrix W that can select a common feature subset, as done in our proposed domain transfer 
feature selection (DTFS) model, which will be explained below.
Specifically, the proposed DTFS model jointly considers two learning domains: 1) AD and 
NC classification as the auxiliary domain, denoted as , where  is a 
sample with d features, NA is the number of samples in the auxiliary domain, and 
 is the corresponding class label (with the AD labeled as +1 
and the NC labeled as −1); 2) MCI-C/MCI-NC classifications as the target domain, denoted 
as  where  is a sample with d features, NT is the number of samples in 
the target domain, and  is the class label (with the MCI-C 
labeled as +1 and the MCI-NC labeled as −1). The DTFS model combines auxiliary domain 
A and target domain T for learning a common weight matrix W = [wA, wT]. Fig. 2(a) gives 
the illustration of DTFS, which optimizes the following objective function with the ‘group 
sparsity’ (i.e., L2/L1-norm) regularization:
(1)
where  W ∈ Rd×t is the weight matrix whose row vector wi is the 
coefficient vector associated with i-th feature across two different learning domains, and b = 
[bA, bT] ∈ R1×t is the intercept for the classification task both in the auxiliary (t = A) and 
target (t = T) domains. Also, β > 0 is a regularization parameter that controls the relative 
contributions of the two terms, and the symbol ′ denotes the transpose of a matrix. 
According to the optimization algorithm of literature [36] for solving the optimization 
problem of Eq.1, we can get the sparse matrix W, where all non-zero row vectors wi 
correspond to features that will be selected, indicating that they are essential for 
classification both on auxiliary and target domains.
2) Domain transfer sample selection (DTSS)—After performing DTFS, we have 
obtained the most informative features in both auxiliary and target domains. In what follows, 
Cheng et al. Page 6













we will compute the cross-domain kernel matrix K for implementing the knowledge fusion 
both on auxiliary and target domains. Here, the instance-transfer approach [37, 38] is used to 
join the auxiliary domain data (i.e., AD and NC subjects which are more separable than 
MCI-C and MCI-NC subjects in the reduced feature space via DTFS), to the target domain 
data (i.e., MCI-C and MCI-NC subjects).
To be specific, we first define the kernel matrices from the auxiliary domain and the target 
domain as:  and , 
respectively. Here,  and  are samples in the auxiliary and target domains, 
respectively, in the reduced feature space via DTFS. Also, as defined before, NA and NT are 
the numbers of samples in the auxiliary and target domains, respectively. Then, we define 
the cross-domain kernel matrices from the auxiliary domain to the target domain and also 
from the target domain to the auxiliary domain as  and 
, respectively. Then the cross-domain kernel matrix K can be 
computed as:
(2)
where N = NA + NT.
In our study, from Eq. (2), three cross-domain kernel matrices are obtained, which 
correspond to three modalities (i.e., MRI, PET and CSF), denoted as K(MRI), K(PET), and 
K(CSF), respectively. Moreover, to remove the noisy samples and seek out the most 
informative samples from multimodal cross-domain, we present a sample selection 
framework via a multi-task Lasso based kernel learning, namely Domain Transfer Sample 
Selection (DTSS). Specifically, in our proposed DTSS model, we first employ the kernel 
learning technique to map sample set from the original space to the kernel space, where 
multi-task Lasso is then performed for sample selection. Fig. 2(b) gives the illustration of 
the proposed DTSS method. From Fig. 2(b), DTSS learns a common weight matrix V = 
[v(MRI), v(PET), v(CSF)], where v(MRI), v(PET), and v(CSF) are the learning weight vectors 
corresponding to MRI, PET and CSF modalities, respectively, and is to solve the following 
objective function:
(3)
Where , V ∈ RN×M is the weight matrix whose row vector νi is the 
vector of coefficients associated with the i-th training sample across three different 
modalities, and M is the number of modalities (M =3 in this study); λ > 0 is a regularization 
parameter that controls the relative contributions of the two terms; and y(m) ∈ RN×1 is the 
corresponding class label of cross-domain for the m-th modality. In addition, K(m) is the 
cross-domain kernel matrix for the m-th modality, i.e., K(MRI), K(PET), and K(CSF), 
respectively, which can be seen as the similarity between pairwise samples in the cross-
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domain for the m-th modality. In our study, the widely used Gaussian kernel function is 
used, which is defined as follows:
(4)
where σ is the bandwidth. Due to the use of ‘group sparsity’ (i.e., L2/L1-norm) 
regularization, many of the rows of V will be zeros, and thus all samples corresponding to 
non-zero row vectors will be selected. In this paper, the SLEP package [39] is used for 
solving the optimization problems in DTFS and DTSS.
3) Domain transfer support vector machines (DTSVM)—After performing DTFS 
and DTSS, we can obtain the most discriminative features and informative samples, upon 
which we will build a domain transfer support vector machines (DTSVM) classifier for final 
classification.
Denote  and  as the new auxiliary and target domains, with the 
corresponding labels denoted as  and , respectively. Here,  and 
, respectively, denote the new auxiliary and target data after feature selection (via DTFS) 
and sample selection (via DTSS), and  and  are the numbers of selected samples. Then, 
we employ multi-kernel learning for multimodal kernel combination [2, 3, 6], which can be 
used to compute the ultimate auxiliary domain kernel matrix KA,A and the cross-domain 
kernel matrix K. Here, kernel combination is used to define a new integrated kernel function 
for the m-th modality data  and  as follows:
(5)
where k(m) denotes the kernel function over the m-th modality, and cm denotes the weight on 
the m-th modality. From Eq. 5, we can achieve the ultimate auxiliary domain kernel matrix 
KA,A and cross-domain kernel matrix K, i.e., , 
. To find the optimal values for weights cm, we constrain them so that Σm 
cm = 1, 0 ≤ cm ≤ 1 and then adopt a coarse-grid search through cross-validation on the 
training samples, which has been shown effective in our previous work [2, 3, 6].
Then, we adopt the adaptive SVMs method in [26] to learn the ultimate classifier f(s). This 
ultimate classifier f(s) is first learned from the auxiliary domain classifier fA(s), which is 
implemented by adding a delta function for cross-domain in the form of Δf(s) = h′ Φ(s) on 
the basis of fA(s):
(6)
where Φ(s) is a kernel-based nonlinear mapping function, and h is the weight vector of 
cross-domain classifier. Also, h′ denotes the transpose of h.
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To learn the weight vector h in Eq. 6, we use the following objective function, similar to the 
SVM:
(7)
where l is the l-th sample in the cross-domain training subset, 
,  represents the total number of 
samples in, and ζl is the slack variable that represents the prediction error of objective 
function of Eq. 7, thus it can be used for nonlinear classification. The parameter C balances 
contributions between auxiliary classifier and cross-domain training examples. According to 
[26], we can solve this objective function (i.e., Eq. 7) to obtain the solution for the weight 
vector h. Then, we can obtain the final solution for f(s). In this study, fA(s) is trained by 
SVM using the ultimate auxiliary domain kernel matrix KA,A, and Δf(s) is solved by Eq.6 
using the ultimate cross-domain kernel matrix K = [k(s, s′)], and k(s, s′) = 〈Φ(s), Φ(s′)〉.
III. RESULTS
A. Experimental Settings
In this study, we use a 10-fold cross-validation strategy to evaluate the performances of 
different methods. Specifically, the set of subjects in the target domain (i.e., 99 MCI 
subjects) are partitioned into 10 subsets (each subset with a roughly equal size), and then 
one subset is successively selected as the test dataset and the remaining subsets are used to 
train the classifiers. This process is repeated 10 times, and the classification performance is 
evaluated by the average sensitivity, specificity, accuracy, and area under curve (AUC) 
measures.
In our experiments, traditional SVM (denoted as SVM) and other methods with the SVM 
algorithm for classification (i.e., DTSVM and our proposed methods) are implemented using 
the LIBSVM toolbox [41] with a linear kernel. For DTFS and DTSS components, sparse 
learning is performed using the SLEP package [39], and regularization parameters β and λ 
are learned using another 10-fold cross-validation strategy on the training data. In DTSS 
component, the similarity function bandwidth parameter σ is also learned using the 10-fold 
cross-validation strategy on the training subsets. Specifically, a hierarchical optimization 
based grid search is employed for searching the optimal parameters. In our experiments, we 
first optimize the regularization parameters β and λ simultaneously through grid search with 
the range of {0.00001, 0.0001, 0.0005, 0.001, 0.004, 0.007, 0.01, 0.02, 0.03, 0.05, 0.06, 
0.08, 0.1, 0.2, 0.4, 0.6, 0.8}, with the fixed default values for other parameters (i.e., σ=2, 
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weights cm: cMRI=0.4, cCSF=0.3, cPET=0.3). Then, we adopt a grid search with the range of 
{2, 4, 8, 16, 32, 64, 128} to optimize the bandwidth parameter σ of similarity function. 
Finally, we use the grid search to find the optimal weights cm in multi-kernel learning. The 
performance of the proposed method was compared with the Laplacian SVM (LapSVM) 
[42]. The LapSVM classifier uses a linear kernel function and its graph Laplacian is 
constructed by using the k nearest neighbor algorithm, where k (1 ≤ k ≤ 10) is learned 
through 10-fold cross-validation on training data.
In addition, we use another similar hierarchical optimization based grid search to search the 
optimal parameters (including k and cm). Specifically, we first find the optimal value for the 
nearest neighbor k with fixed values for weights cm (i.e., cMRI=0.4, cCSF=0.3, cPET=0.3), and 
then determine the optimal weights cm in multi-kernel learning through cross-validation. 
Multi-modality and single-modality biomarkers are used for testing the classification 
performance of the proposed method, and a multi-kernel learning method is used to combine 
multi-modality biomarkers (i.e., MRI, CSF and PET) for all classification methods. In 
particular, multi-kernel learning implement a grid search with range from 0 to 1 and step 
size 0.1 on the training subsets. It is worth noting that, for optimization of all parameters, it 
is performed on the training subset by an inner 10-fold cross-validation. In addition, the 
same feature normalization scheme as in [2] is used in our experiments.
B. Classification results for recognizing MCI-C and MCI-NC patients
To investigate the effectiveness of the proposed method, we first evaluate the classification 
performance of our method for recognizing MCI-C and MCI-NC patients using both multi-
modality and single-modality biomarkers. Table 2 shows the classification performance of 
five different methods, including SVM (traditional SVM), SVM+SLR, DTSVM [29], 
LapSVM [42], and the proposed method (i.e., DTFS+DTSS+DTSVM). We also perform 
DeLong's method [53] on the AUC between the proposed method and each of other four 
comparison methods, with the corresponding p-values shown in Table 2. Note that DeLong's 
test is a nonparametric statistical test for comparing AUC between two ROC curves, which 
can be employed to assess statistical significance via computing z-scores for the AUC 
estimate [54, 55]. Here, SLR denotes a sparse feature selection method with logistic 
regression loss function [43], and ‘SVM+SLR’ represents the method that first applies SLR 
for feature selection and then adopts SVM for classification. Note that each value in Table 2 
is the averaged result of the 10-fold cross-validation, which was performed 10 different 
times. In addition, we plot the ROC curves achieved by different methods in Fig. 3.
As can be seen in Table 2 and Fig. 3, the proposed method consistently outperforms SVM, 
SVM+SLR, DTSVM and LapSVM in terms of the classification accuracy, sensitivity and 
AUC measures. Also, Table 2 indicates that both the proposed method and DTSVM 
significantly outperform SVM and SVM+SLR methods, while LapSVM is only slightly 
better than SVM. Moreover, statistical test measures via DeLong's method [53] (i.e., p-
value) demonstrate the superiority of the proposed method over other comparison methods. 
These results imply that using knowledge learned from auxiliary domain (i.e., AD/NC 
classification) can effectively improve the performance of MCI-C/MCI-NC classification. 
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These results also suggest that transfer learning is more suitable than semi-supervised 
learning for the case of data coming from different domains.
On the other hand, to investigate the relative contributions of the three components (i.e., 
DTFS, DTSS, and DTSVM) in our proposed method, we compare our method with its three 
variants, i.e., DTSVM, DTSS+DTSVM, and DTFS+DTSVM, with experimental results 
shown in Table 3. It is worth noting that, DTSS+DTSVM is based on DTSVM classifier 
using only the DTSS sample selection method, and DTFS+DTSVM is also based on 
DTSVM classifier using only the DTFS feature selection method. For using CSF 
biomarkers, feature selection was not performed because there are only three features in 
CSF. In Fig. 4, we also plot the ROC curves achieved by different methods using both multi-
modality and single-modality biomarkers, respectively. In addition, we also report the p-
values, which are computed by DeLong's method [53] on the AUC between the proposed 
method and its other three variants methods in Table 3.
From Table 3 and Fig. 4, each component can boost the classification performance 
compared with SVM. It is worth noting that, according to Fig. 4 and statistical significance 
assessment in Table 3, the MRI features (as opposed to PET and CSF biomarkers) most 
benefit from the proposed method as compared with other individual components (DTSVM, 
DTSS, and DTFS). This observation shows that using MRI features in the auxiliary domain 
can more efficiently capture those discriminative features between MCI-C and MCI-NC 
patients, than using PET or CSF features. Also, it indicates that the structural changes in a 
brain from MRI scans are more distinctive than the changes in a brain reflected by PET and 
CSF biomarkers. In general, our proposed method that integrates all the three components 
together achieves the best performance.
C. Discriminative brain regions detection
To evaluate the efficacy of our proposed domain transfer feature selection (DTFS) method 
for detecting the discriminative brain regions, we compare our proposed DTFS method with 
the commonly used single-domain based feature selection methods including paired t-test 
and sparse logistic regression (SLR) [43]. It is worth noting that in the feature selection step, 
both paired t-test and SLR methods only use data from target domain (i.e., MCI-C/MCI-NC) 
while DTFS uses data from both target and auxiliary (i.e., AD/NC) domains. In addition, we 
also compare our method with a baseline method where all features are used (i.e., no feature 
selection). For evaluating the performances of different feature selection methods including 
DTFS, paired t-test, SLR and Baseline, the classifier DTSVM is used for subsequent 
classification after feature selection. Table 4 shows results achieved by different feature 
selection methods. Here, each value in Table 4 is the averaged result of 10-fold cross-
validation strategy in 10 independent runs. In addition, we also compute the p-value on the 
AUC between the DTFS method and other three methods via DeLong's method [53], which 
is shown in Table 4. As can be seen from Table 4, for MRI biomarker, there is no statistical 
significance between the DTFS and SLR (P=0.054), and also for PET biomarker, there is no 
statistical significance between the DTFS and the Baseline method (P=0.063). In general, in 
most cases our proposed DTFS method outperforms the other three methods, which suggests 
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that the combination of auxiliary and target domains may provide complementary 
information for seeking out the most discriminative brain regions.
Furthermore, we list all selected brain regions with the highest frequency of occurrence by 
DTFS on MRI and PET images in Table 5. Here, to get these features (i.e., brain regions), 
we count the frequency of each feature and selected across all folds and all runs (i.e., a total 
of 100 times for 10-fold cross-validation with 10 independent runs), and then regarded those 
features with frequency of 100 (i.e., always selected in all folds and all runs) as selected 
stable features. On the other hand, in the supplementary Tables S1 and S2, we also listed all 
selected stable brain regions by paired t-test and SLR methods on MRI and PET images, 
respectively.
Finally, Fig. 5 visually shows the selected brain regions with the highest frequency of 
occurrence by DTFS, paired t-test and SLR on MRI and PET images, respectively. As can 
be seen from Fig. 5, our proposed DTFS method successfully finds out the most 
discriminative brain regions (e.g., hippocampal, amygdala, temporal lobe, precuneus, and 
insula) that are known to be related to Alzheimer’s disease [3, 4, 44, 45].
IV. DISCUSSION
In this paper, we propose a domain transfer learning framework to recognize MCI-C and 
MCI-NC patients by using AD and NC subjects as auxiliary domain. We have evaluated the 
performance of our method on 202 baseline subjects from ADNI database, and the 
experimental results show that our proposed method can consistently and substantially 
improve the classification performance, with an overall classification accuracy of 79.4% for 
recognizing MCI-C and MCI-NC patients.
A. Domain transfer learning
Domain transfer learning is a recently-developed machine learning technique, which is able 
to learn a set of related models from the target domain and its related auxiliary domain for 
improving the classification performance in target domain [26–28, 38, 46]. Different from 
conventional machine learning methods, domain transfer learning does not require target 
and auxiliary domains having the same data distribution [38, 46], and it can effectively use 
data from auxiliary domain for improving the performance in the target domain [26–28, 38, 
46]. However, to the best of our knowledge, there are few studies using domain transfer 
learning for neuroimaging based diagnosis of brain diseases [29, 47]. It is worth noting that 
in our preliminary study [29], domain transfer learning is performed only on the 
classification stage (i.e., DTSVM). To further improve the performance, we implement 
domain transfer learning throughout the whole process including domain transfer feature 
selection (i.e., DTFS), domain transfer sample selection (i.e., DTSS) and domain transfer 
classification (i.e., DTSVM). Our experimental results have validated the efficacy of the 
proposed domain transfer learning method for recognizing MCI-C and MCI-NC patients.
Recently, many studies in early diagnosis of AD focus on predicting the conversion of MCI 
to AD, i.e., identifying the MCI-C from MCI-NC [3, 4, 7, 13, 15, 17, 20, 23–25, 45, 48–51]. 
Several studies adopted the correlated domain knowledge to design classifiers, or feature 
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selection methods for predicting the conversion from MCI to AD [3, 49, 50]. The regression 
based biomarkers and multiple clinical variables (MMSE and ADAS-Cog scores) were used 
as auxiliary domain knowledge for feature selection in the literatures [3, 49]. And 
researchers in [50] proposed an improved multi-task feature selection method for finding 
discriminative brain regions using multi-modality data (MRI and PET). Different from the 
above studies, our method adopts more informative auxiliary domain knowledge (i.e., 
AD/NC learning task) for feature selection. For the validity of using AD/NC learning task as 
auxiliary domain, we applied the method of [3, 49] on our used dataset (i.e., 99 MCI, and 
their corresponding MMSE and ADAS-Cog scores), and achieved an accuracy of 71.7% and 
an AUC of 0.766 using the three modalities data (i.e., MRI, PET, and CSF). Also, we apply 
the method of [50] on the dataset used in this study, and achieve an accuracy of 67.8% and 
an AUC of 0.696 with two modalities data (i.e., MRI and PET). Especially, our method 
achieve an accuracy of 79.4% and an AUC of 0.848 with three modalities data (i.e., MRI, 
PET and CSF), and achieve an accuracy of 77.3% and an AUC of 0.842 with two modalities 
data (i.e., MRI and PET). This result further validates our assumption that using AD and NC 
subjects as auxiliary domain can significantly improve the performance of MCI-C/MCI-NC 
classification.
In addition, our current study uses only AD and NC subjects as auxiliary domain. However, 
according to the principle of domain transfer learning, multiple auxiliary domain knowledge 
can also be utilized, as long as these multi-domain learning tasks are related to the target-
domain learning task. Therefore, other relevant learning tasks, e.g., data of other dementia 
type, could be utilized to further promote the learning performances of our proposed 
methods.
B. Validation and Optimizing
To evaluate the performance of our proposed domain transfer learning method, the 10-fold 
cross-validation strategy was adopted. Besides the outer 10-fold cross-validation, we further 
perform an inner 10-fold cross-validation on the training data, to find the optimal 
parameters. Our proposed method is evaluated on 43 MCI-C and 56 MCI-NC subjects, 
which include 93 MRI features and 93 PET features extracted from the original MR and 
PET images, as well as 3 CSF features. To overcome the potential over-fitting problem 
caused by the issue of small sample size (i.e., the sample size is considerably smaller than 
the feature dimensionality), we propose a domain transfer feature selection method to select 
the most discriminative features. Similar to several studies in early diagnosis of AD [3, 13, 
44, 49–51, 58] where many machine learning methods were developed for selecting 
discriminative brain regions, our proposed method can also be used for detecting 
discriminative brain regions from a larger number of brain images on the clinical 
application. In addition, according to our experimental results, we found that the over-fitting 
issue rarely occurs, because of the following two possible reasons. First, the number of 
samples is comparable to the number of features after feature selection (DTFS). Second, 
instead of simply concatenating multimodal features into a long vector, the multi-kernel 
SVM [2] we adopted can compute kernel matrices by using feature subsets from individual 
modalities, which helps avoid the over-fitting problem.
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In this paper, a hierarchical optimization based coarse-grid search is employed for searching 
optimal parameters (i.e., β, λ, σ, and cm). Using this optimization strategy, it cannot 
guarantee the joint optimality of parameter values. For addressing this problem, we further 
design an iterative optimization algorithm to find the optimal parameters jointly. 
Specifically, we first perform a grid search to find the optimal parameters β and λ. With 
determination of these parameters, we then optimize other parameters (i.e., σ and cm). 
Afterwards, the above procedures are reported iteratively. In Fig. 6, we plot the change of 
the classification accuracy with respect to different iterations using the iterative optimization 
algorithm.
As shown in Fig. 6, the accuracy first rises with the increase of iteration number, and then 
keep stable when the iteration number is larger than 3. However, it is very time-consuming 
to perform such iterative optimization algorithm. We plan to adopt such iterative 
optimization strategy to find the optimal parameters in the future for further boosting the 
classification performance.
C. Predicting the conversion of MCI to AD
As mentioned above, many studies in early diagnosis of AD focus on predicting the 
conversion of MCI to AD using multi-modality data [3, 4, 10, 22, 23, 50, 52]. Accordingly, 
we report some representative results as follows.
In [3], a multi-task feature selection method achieved an accuracy of 73.9% and an AUC of 
0.797 on 43 MCI-C and 48 MCI-NC ADNI subjects by using multi-modality data (MRI, 
FDG-PET and CSF). The method proposed in [4], which combines statistical analysis and 
pattern classification methods, achieved an accuracy of 62% and an AUC of 0.734 on 69 
MCI-C and 170 MCI-NC ADNI subjects by using multi-modality data (MRI and CSF). 
Also, researchers in [10] proposed a multi-kernel pattern classification method, achieving an 
AUC of 0.791 on 119 MCI ADNI subjects with multi-modality data (including MRI, FDG-
PET, CSF, and APOE). Researchers in [22] proposed a multivariate data analysis method 
and achieved an accuracy of 68.5% and an AUC of 0.76 on 81 MCI-C and 81 MCI-NC 
ADNI subjects with multi-modality data (i.e., MRI and CSF). In [23], a Gaussian process 
classification method was proposed and achieved an accuracy of 74.1% and an AUC of 
0.795 on 47 MCI-C and 96 MCI-NC ADNI subjects with multi-modality data (i.e., MRI, 
FDG-PET, CSF, and APOE). By using the data employed in this study, we apply the 
Gaussian process classification method proposed in [23], and achieve an accuracy of 72.1% 
and an AUC of 0.797. In [50], an inter-modality relationship constrained multi-task feature 
selection method was proposed, which achieved an accuracy of 67.8% and an AUC of 0.696 
on 43 MCI-C and 56 MCI-NC ADNI subjects with MRI and FDG-PET data. Trzepacz et al. 
[52] used a statistical analyses method and achieved an accuracy of 76% on 20 MCI-C and 
30 MCI-NC ADNI subjects by using MRI, FDG-PET, and PIB-PET data. As shown in 
Section IV, our proposed domain transfer learning classification method achieves an 
accuracy of 79.4% and an AUC of 0.848 with three modalities (i.e., MRI, FDG-PET, and 
CSF).
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D. Extension for recognizing MCI and AD/NC
To further investigate the efficacy of our proposed domain transfer learning method, besides 
recognizing MCI-C and MCI-NC, we also apply our method for recognizing MCI and 
AD/NC. Specifically, we have two new classification tasks, i.e., MCI vs. NC classification 
and MCI vs. AD classification. It is worth noting that, AD subjects are regarded as the 
auxiliary data for MCI vs. NC classification, and NC subjects are regarded as the auxiliary 
data for MCI vs. AD classification. In the Appendix, we show the experimental results by 
comparing different methods with both multi-modality and sing-modality biomarkers for 
MCI vs. NC classification and MCI vs. AD classification in Table S3 and Table S4, 
respectively.
As we can see from Table S3 and Table S4, our proposed method achieves consistently 
better performance than other methods in terms of four performance evaluation measures. 
Specifically, for multi-modality case, our proposed method achieves the classification 
accuracy of 86.4%, sensitivity of 92.8%, specificity of 73.8%, and AUC of 0.924 in MCI vs. 
NC classification; and the classification accuracy of 82.7%, sensitivity of 89.2%, specificity 
of 69.6%, and AUC of 0.906 in MCI vs. AD classification.
In addition, we also list the results achieved by different variants of our proposed method in 
Table S5 and Table S6 in the Appendix. Table S5 and S6 indicate that our method that 
integrates all the three components together achieves the best performance. These results 
further validate the efficacy of our proposed domain transfer learning method that uses data 
from auxiliary domain for aiding the classification in the target domain.
E. Limitations
The current study is limited by several factors. First, our proposed method is based on the 
single auxiliary domain data (i.e., AD and NC) from the ADNI database. In the future work, 
we will investigate whether using data from more auxiliary domains (e.g., fMRI or PIB-PET 
data, or even the related disease data, e.g., vascular dementia) can further improve the 
performance. Second, our current method cannot deal with subjects with incomplete multi-
modality of data (i.e., missing of some modalities of data) and thus used only 202 subjects 
with all three modalities of data in ADNI. It is interesting to extend our current method for 
dealing with subjects with missing modalities of data for further improvement of 
performance, which is also one of our future works. Finally, in the current study we 
computed the total PET signal from each ROI, but did not perform any partial volume 
correction based on the segmented tissues from MR image. For further performance 
improvement, in our future work we will address the issues of partial volume effect and 
different point spread functions between modalities.
V. CONCLUSION
In this paper, we propose a general domain transfer learning based framework that consists 
of domain transfer feature selection (DTFS), domain transfer sample selection (DTSS) and 
domain transfer support vector machine (DTSVM), for MCI conversion prediction. Here, 
the main idea of our domain transfer learning based method is to exploit the auxiliary 
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domain data (AD/NC subjects) to improve the classification between MCI-C and MCI-NC 
in the target domain. To the best of our knowledge, our study is among the first in 
neuroimaging to use and transfer the knowledge learned from the auxiliary task with 
multimodal data (i.e., AD vs. NC classification) for guiding the target task (i.e., MCI-C vs. 
MCI-NC classification). We have validated the efficacy of our proposed method using 202 
subjects from the ADNI database with multi-modality data (including MRI, FDG-PET and 
CSF). The experimental results show that our proposed method achieves significantly better 
performance than the traditional methods for MCI conversion prediction, by effectively 
adopting the extra domain knowledge learned from AD and NC.
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The system diagram of our proposed classification framework.
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Illustration on the proposed DTFS and DTSS models. (a) Using DTFS to select 
discriminative brain regions. (b) Using DTSS to select informative subjects.
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ROC curves of different methods for MCI-C/MCI-NC classification with multi-modality 
and single-modality data, respectively.
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ROC curves of different variants of our proposed method.
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Selected stable brain regions by three different methods on (Top) MRI and (Bottom) PET 
images. Note that different colors indicate different brain regions.
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Classification accuracy of our proposed method in multimodal case with respect to different 
iterations, achieved by iterative optimization algorithm.
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Age (mean ± SD) 75.2±7.4 75.3±5.2 75.8±6.8 74.7±7.7
Education (mean ± SD) 14.7±3.6 15.8±3.2 16.1±2.6 16.1±3.0
MMSE (mean ± SD) 23.8±2.0 29.0±1.2 26.6±1.7 27.5±1.5
CDR (mean ± SD) 0.7±0.3 0.0±0.0 0.5±0.0 0.5±0.0
AD = Alzheimer’s Disease, NC = Normal Control, MCI = Mild Cognitive Impairment, MCI-C = MCI converter, MCI-NC = MCI non-converter, 
MMSE = Mini-Mental State Examination, CDR = Clinical Dementia Rating.

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Cheng et al. Page 30
Table 5
Selected brain regions by the DTFS method on MRI and PET images, respectively.
MRI (Brain regions) PET (Brain regions)
amygdala right angular gyrus left
anterior limb of internal capsule left amygdala right
entorhinal cortex left cuneus right
inferior frontal gyrus right inferior occipital gyrus left
temporal lobe WM left inferior temporal gyrus left
inferior temporal gyrus right hippocampal formation right
insula left lingual gyrus left
fornix left middle frontal gyrus left
hippocampal formation left medial frontal gyrus right
perirhinal cortex left middle occipital gyrus left
precuneus left middle temporal gyrus left
precentral gyrus left precuneus left
superior parietal lobule right postcentral gyrus right
supramarginal gyrus left superior frontal gyrus right
superior parietal lobule left temporal pole right
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